Verition Fund Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $994K | Sell |
27,631
-2,514
| -8% | -$90.5K | ﹤0.01% | 1858 |
|
|
2025
Q1 | $1.19M | Buy |
30,145
+10,680
| +55% | +$421K | 0.01% | 1523 |
|
|
2024
Q4 | $586K | Sell |
19,465
-26,234
| -57% | -$790K | ﹤0.01% | 1799 |
|
|
2024
Q3 | $1.07M | Sell |
45,699
-6,613
| -13% | -$155K | 0.01% | 1293 |
|
|
2024
Q2 | $931K | Buy |
52,312
+35,655
| +214% | +$634K | 0.01% | 1195 |
|
|
2024
Q1 | $253K | Buy |
16,657
+2,553
| +18% | +$38.8K | ﹤0.01% | 1791 |
|
|
2023
Q4 | $241K | Sell |
14,104
-39,003
| -73% | -$666K | ﹤0.01% | 1487 |
|
|
2023
Q3 | $444K | Buy |
53,107
+38,292
| +258% | +$320K | 0.01% | 1237 |
|
|
2023
Q2 | $368K | Sell |
14,815
-10,180
| -41% | -$253K | ﹤0.01% | 1210 |
|
|
2023
Q1 | $376K | Buy |
+24,995
| New | +$376K | 0.01% | 1279 |
|